Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 3
This trial is looking at a drug called olaparib for women who have ovarian cancer, fallopian tube cancer or primary peritoneal cancer with a change to a gene called BRCA1 or BCRA2.
Recruitment start: 7 October 2013
Recruitment end: 14 November 2014
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Charlie Gourley
AstraZeneca
NIHR Clinical Research Network: Cancer
Last reviewed: 24 Nov 2014
CRUK internal database number: 11331
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
